Market Cap 151.73M
Revenue (ttm) 118.71M
Net Income (ttm) -30.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 782.33
Profit Margin -25.59%
Debt to Equity Ratio 0.52
Volume 274,300
Avg Vol 371,184
Day's Range N/A - N/A
Shares Out 6.46M
Stochastic %K 78%
Beta 0.52
Analysts Hold
Price Target $24.43

Company Profile

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut sy...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 224 419 7106
Fax: 510 744 8001
Address:
100 South Saunders Road, Suite 300, Lake Forest, United States
haddykatz
haddykatz Jun. 16 at 1:17 AM
$ASRT assume they got to 50% ??
0 · Reply
Chuckuk
Chuckuk Jun. 15 at 8:21 PM
$ASRT The key catch is procedure. To preserve appraisal, a holder generally must not tender, or must withdraw before acceptance; must make a written appraisal demand in time; must keep holding through the merger; and then someone must file an appraisal petition within 120 days after the effective time. Assertio says it has no intention of filing that petition for holders, so the burden is on dissenting holders. The stronger legal themes remain the net-cash value, the Cosette retained upside, the removal/loss of CVR protection, Rolvedon’s strategic value, same-day dosing upside, and whether the board’s process really extracted full value. The company’s own disclosure says the Zydus structure is tender plus second-step merger at $23.50, with Nasdaq expecting suspension mechanics if the deal proceeds. So closing may end the stock-market fight, but not necessarily the legal fight.
0 · Reply
COUNSELOR18
COUNSELOR18 Jun. 15 at 7:22 PM
0 · Reply
Chuckuk
Chuckuk Jun. 15 at 2:14 PM
$ASRT We may see people running for the hills but my advice is if you want some limited compensation you need not to make a deal with the... You will be seen as accepting what my opinion says is unacceptable.
0 · Reply
Chuckuk
Chuckuk Jun. 15 at 11:47 AM
$ASRT Well today is the day for the numbers we will see what this brings hoping it needs an uplift to deliver the numbers for the tender I guess we will know at or around open tomorrow. Good luck all who are holding and waiting I hope that is the majority.
1 · Reply
Polo2024
Polo2024 Jun. 14 at 11:57 PM
$ASRT Not tendering. Management has been criminal to shareholders. It's frankly disgusting how the management of ASRT is rewarding themselves with multimillion dollar golden parachutes at SH expense- how is this even legal after they destroyed SH value?
1 · Reply
7NEWLIFE
7NEWLIFE Jun. 12 at 8:44 AM
$ASRT Next stop $ 26.50 per share. I personally believe this will be the next move higher but I am not a financial advisor.
2 · Reply
Chuckuk
Chuckuk Jun. 12 at 4:29 AM
$ASRT I have sent another email to Monteverde Law confirming previous mails sent and in reply to their acknowledgments. I explained I will not be tendering and seek redress along Revlon principles. Monday is likely the day of reckoning on tender numbers we will wait and see. To anyone who reads this from Zydus thank you in some ways (though not for the Indocin intervention in 23) an extra $60M in the pot would silence many. $35 is a fair price per share based on bidder L's offer ex cash and the Cosette deal was plainly wrong but will give you a CVR. All IMHO a holder since 2016 in ASRT pre Malinkroft should have sold in 2023 at over $100.
0 · Reply
smallfish78
smallfish78 Jun. 11 at 10:17 PM
$ASRT Fuck Zydus!
1 · Reply
Chuckuk
Chuckuk Jun. 11 at 8:17 PM
$ASRT price is too low
0 · Reply
Latest News on ASRT
Assertio, Garda agree to delay launch of tender offer

2026-05-08T17:52:08.000Z - 5 weeks ago

Assertio, Garda agree to delay launch of tender offer


Assertio Holdings Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 5 weeks ago

Assertio Holdings Quarterly report: Q1 2026


Assertio Provides Update on Garda Therapeutics Tender Process

Apr 21, 2026, 5:00 PM EDT - 7 weeks ago

Assertio Provides Update on Garda Therapeutics Tender Process


Assertio downgraded to Hold from Buy at Maxim

2026-04-09T17:35:14.000Z - 2 months ago

Assertio downgraded to Hold from Buy at Maxim


Assertio downgraded to Hold from Buy at Lake Street

2026-04-09T13:04:39.000Z - 2 months ago

Assertio downgraded to Hold from Buy at Lake Street


Assertio downgraded to Neutral from Buy at H.C. Wainwright

2026-04-09T10:12:06.000Z - 2 months ago

Assertio downgraded to Neutral from Buy at H.C. Wainwright


Assertio Holdings Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Assertio Holdings Proxy statement: Proxy filing


Assertio Holdings Earnings Call Transcript: Q4 2025

Mar 16, 2026, 4:30 PM EDT - 3 months ago

Assertio Holdings Earnings Call Transcript: Q4 2025


Assertio Holdings Annual report: Q4 2025

Mar 16, 2026, 4:30 PM EDT - 3 months ago

Assertio Holdings Annual report: Q4 2025


Assertio Holdings Earnings release: Q4 2025

Mar 16, 2026, 4:30 PM EDT - 3 months ago

Assertio Holdings Earnings release: Q4 2025


Assertio regains compliance with Nasdaq listing requirements

2026-01-12T21:21:26.000Z - 5 months ago

Assertio regains compliance with Nasdaq listing requirements


Assertio Therapeutics trading halted, news pending

2025-12-24T21:50:25.000Z - 6 months ago

Assertio Therapeutics trading halted, news pending


Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

Dec 22, 2025, 4:30 PM EST - 6 months ago

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split


Assertio Holdings Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 7 months ago

Assertio Holdings Earnings Call Transcript: Q3 2025


Assertio Holdings Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 7 months ago

Assertio Holdings Quarterly report: Q3 2025


Assertio Holdings Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 7 months ago

Assertio Holdings Earnings release: Q3 2025


Assertio Reports Third Quarter 2025 Financial Results

Nov 10, 2025, 4:13 PM EST - 7 months ago

Assertio Reports Third Quarter 2025 Financial Results


Assertio Announces Leadership Transition

Oct 28, 2025, 9:15 AM EDT - 8 months ago

Assertio Announces Leadership Transition


Assertio Holdings Earnings Call Transcript: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 11 months ago

Assertio Holdings Earnings Call Transcript: Q2 2025


Assertio Holdings Quarterly report: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 11 months ago

Assertio Holdings Quarterly report: Q2 2025


Assertio Holdings Earnings release: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 11 months ago

Assertio Holdings Earnings release: Q2 2025


Assertio Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:05 PM EDT - 11 months ago

Assertio Reports Second Quarter 2025 Financial Results


Assertio Holdings Slides: Corporate Presentation

May 21, 2025, 7:00 AM EDT - 1 year ago

Assertio Holdings Slides: Corporate Presentation


Assertio Holdings Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings Call Transcript: Q1 2025


Assertio Holdings Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Quarterly report: Q1 2025


Assertio Holdings Earnings release: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings release: Q1 2025


Assertio Reports First Quarter 2025 Financial Results

May 12, 2025, 4:01 PM EDT - 1 year ago

Assertio Reports First Quarter 2025 Financial Results


Assertio Holdings Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Assertio Holdings Proxy statement: Proxy Filing


Assertio Holdings Proxy statement: Proxy Filing

Mar 25, 2025, 8:00 AM EDT - 1 year ago

Assertio Holdings Proxy statement: Proxy Filing


Assertio Holdings Earnings Call Transcript: Q4 2024

Mar 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings Call Transcript: Q4 2024


Assertio Holdings Annual report: Q4 2024

Mar 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Annual report: Q4 2024


Assertio Holdings Earnings release: Q4 2024

Mar 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings release: Q4 2024


Assertio Holdings Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Assertio Holdings Earnings Call Transcript: Q3 2024


Assertio Holdings Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Assertio Holdings Quarterly report: Q3 2024


Assertio Holdings Earnings release: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Assertio Holdings Earnings release: Q3 2024


Assertio Reports Third Quarter 2024 Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Assertio Reports Third Quarter 2024 Financial Results


Assertio Provides Response to Letter from Short-seller

Nov 11, 2024, 7:30 AM EST - 1 year ago

Assertio Provides Response to Letter from Short-seller


Assertio Holdings Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Assertio Holdings Earnings Call Transcript: Q2 2024


Assertio Holdings Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Assertio Holdings Quarterly report: Q2 2024


Assertio Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 2 years ago

Assertio Reports Second Quarter 2024 Financial Results


haddykatz
haddykatz Jun. 16 at 1:17 AM
$ASRT assume they got to 50% ??
0 · Reply
Chuckuk
Chuckuk Jun. 15 at 8:21 PM
$ASRT The key catch is procedure. To preserve appraisal, a holder generally must not tender, or must withdraw before acceptance; must make a written appraisal demand in time; must keep holding through the merger; and then someone must file an appraisal petition within 120 days after the effective time. Assertio says it has no intention of filing that petition for holders, so the burden is on dissenting holders. The stronger legal themes remain the net-cash value, the Cosette retained upside, the removal/loss of CVR protection, Rolvedon’s strategic value, same-day dosing upside, and whether the board’s process really extracted full value. The company’s own disclosure says the Zydus structure is tender plus second-step merger at $23.50, with Nasdaq expecting suspension mechanics if the deal proceeds. So closing may end the stock-market fight, but not necessarily the legal fight.
0 · Reply
COUNSELOR18
COUNSELOR18 Jun. 15 at 7:22 PM
0 · Reply
Chuckuk
Chuckuk Jun. 15 at 2:14 PM
$ASRT We may see people running for the hills but my advice is if you want some limited compensation you need not to make a deal with the... You will be seen as accepting what my opinion says is unacceptable.
0 · Reply
Chuckuk
Chuckuk Jun. 15 at 11:47 AM
$ASRT Well today is the day for the numbers we will see what this brings hoping it needs an uplift to deliver the numbers for the tender I guess we will know at or around open tomorrow. Good luck all who are holding and waiting I hope that is the majority.
1 · Reply
Polo2024
Polo2024 Jun. 14 at 11:57 PM
$ASRT Not tendering. Management has been criminal to shareholders. It's frankly disgusting how the management of ASRT is rewarding themselves with multimillion dollar golden parachutes at SH expense- how is this even legal after they destroyed SH value?
1 · Reply
7NEWLIFE
7NEWLIFE Jun. 12 at 8:44 AM
$ASRT Next stop $ 26.50 per share. I personally believe this will be the next move higher but I am not a financial advisor.
2 · Reply
Chuckuk
Chuckuk Jun. 12 at 4:29 AM
$ASRT I have sent another email to Monteverde Law confirming previous mails sent and in reply to their acknowledgments. I explained I will not be tendering and seek redress along Revlon principles. Monday is likely the day of reckoning on tender numbers we will wait and see. To anyone who reads this from Zydus thank you in some ways (though not for the Indocin intervention in 23) an extra $60M in the pot would silence many. $35 is a fair price per share based on bidder L's offer ex cash and the Cosette deal was plainly wrong but will give you a CVR. All IMHO a holder since 2016 in ASRT pre Malinkroft should have sold in 2023 at over $100.
0 · Reply
smallfish78
smallfish78 Jun. 11 at 10:17 PM
$ASRT Fuck Zydus!
1 · Reply
Chuckuk
Chuckuk Jun. 11 at 8:17 PM
$ASRT price is too low
0 · Reply
Chuckuk
Chuckuk Jun. 11 at 5:58 PM
$ASRT https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-asrt/assertio-holdings/mfg6hf2j-digital-health-and-non-opioid-therapies-will-transform-pain-management/updates/5-5-assertio-holdings-updated-analyst-fair-value-estimate-has-s?utm_source=Braze&utm_medium=email&utm_campaign=CommunityDigest
0 · Reply
Chuckuk
Chuckuk Jun. 11 at 4:38 PM
$ASRT I hope we can hold this off to get an uplift the business and the CASH is worth far more than the Zydus offer just compare this to Bidder L who offered $170M for Rolvedon ALONE with no requirement for the cash. So we shareholders would be $100M better off roughly and that is $16 bucks more per share than the offer from Zydus.
0 · Reply
Pitulolo
Pitulolo Jun. 11 at 3:40 PM
$ASRT Since you hold shares of Assertio Holdings Inc. (US04546C3043), we are informing you about the following corporate event concerning this company. What does this mean? There is a tender offer for the shares of Assertio Holdings Inc. (US04546C3043). The offer price is USD 23.50 per share. Therefore, this offer applies to the shares you hold in your DEGIRO account. The objective of the offer is to acquire all remaining outstanding shares. However, please note that this corporate action may be subject to pro rata allocation and certain restrictions, such as country-specific restrictions. Consequently, your request may not be fully considered. It will be processed on a best-effort basis. Please be aware that this offer may be subject to withholding tax or other additional costs. You can find more information about this offer on the company's Investor Relations page. You can also find more information about Corporate Shares in our Help Center.
1 · Reply
Chuckuk
Chuckuk Jun. 11 at 10:59 AM
$ASRT A few days to go before we find out if enough shares have been tendered I am not tendering as I believe the process was faulty and the Board failed SHs I will support the case to this effect. If you have tendered you can retract if you leave it I believe you have accepted the status quo. It is your decision I have made mine! I will not Tender and have said no. I would accept $35 grudgingly but bidder L was offering far more abd we could keep the cash?
1 · Reply
Invest2live
Invest2live Jun. 10 at 8:12 PM
$ASRT 128% already; congrats 🌿🌷🔆 Checkout $RXRX and $GAU for long.
1 · Reply
AceNeddy
AceNeddy Jun. 10 at 4:19 PM
$ASRT so I guess no tender? And wait for maybe higher price?
1 · Reply
Luckybreak
Luckybreak Jun. 10 at 1:22 PM
$ASRT Go figure this one out Our beloved management wanted us to tender at $18 per share .We the long time retail share holders of ASRT/SPPI/combined ASRT helped the salary of management going while we waited for a somewhat face saving exit .There you have it /I for one can’t explain.There is a saying when you dig for worm for fishing bait you may find a snake . Unbelievable
0 · Reply
Polo2024
Polo2024 Jun. 10 at 1:57 AM
$ASRT Can we hear a single reason why to tender ??????
1 · Reply
gain100percent
gain100percent Jun. 9 at 8:02 PM
$ASRT I'll keep declining until the tender reaches $65
0 · Reply
GovenekFfydd
GovenekFfydd Jun. 9 at 7:34 PM
$ASRT What happens if I don't tender shares by the deadline, do I lose them, do they forcibly take? Not trying to be stupid here, but just never had this situation before.
1 · Reply
TwongStocks
TwongStocks Jun. 9 at 6:48 PM
$ASRT Equity Corporate Actions Alert #2026 - 393 Information Regarding the Tender Offer of Assertio Holdings, Inc. (ASRT) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-393 The tender offer by Zydus Worldwide DMCC to acquire all of the outstanding common stock of Assertio Holdings, Inc. (ASRT) is scheduled to expire one minute after 11:59 PM ET on June 15, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on June 16, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on June 15, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (June 16) and will be suspended effective June 17, 2026. Tender offer: ASRT shareholders will receive $23.50 for each share held.
1 · Reply
Chuckuk
Chuckuk Jun. 9 at 6:03 PM
$ASRT sqeeeeeze
0 · Reply